STAT3, a Master Regulator of Anti-Tumor Immune Response
- PMID: 31480382
- PMCID: PMC6770459
- DOI: 10.3390/cancers11091280
STAT3, a Master Regulator of Anti-Tumor Immune Response
Abstract
Immune cells in the tumor microenvironment regulate cancer growth. Thus cancer progression is dependent on the activation or repression of transcription programs involved in the proliferation/activation of lymphoid and myeloid cells. One of the main transcription factors involved in many of these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on the role of STAT3 and its regulation, e.g. by phosphorylation or acetylation in immune cells and how it might impact immune cell function and tumor progression. Moreover, we will review the ability of STAT3 to regulate checkpoint inhibitors.
Keywords: CD4+ T cells; CD8+ T cells; STAT3; cancer; immune check point.; myeloid cells.
Conflict of interest statement
The authors declare no conflict of interest.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
